Associate Professor of Pediatrics, Penn State College of Medicine
Pediatric Hematology & Oncology
Dr. Lisa M. McGregor, MD
|
|
Give Review
Dr. Lisa M. McGregor works in the field of Pediatric Hematology & Oncology. He went to medical school at Johns Hopkins University School of Medicine. Johns Hopkins University School of Medicine is one of the top medical schools in the US. Johns Hopkins University School of Medicine is ranked 3/29 in Research/PrimaryCare. He has 1 awards "Fellow (FAAP)". Doctor Lisa M. McGregor, MD is a published MD. He has 30 publications published. The most current publication "Expression and function of Trk-C in favourable human neuroblastomas."
Publications
- Phase I dose escalation and pharmacokinetic study of oral gefitinib and irinotecan in children with refractory solid Tumors.
- Phase I Clinical Trial of Ifosfamide, Oxaliplatin, and Etoposide (IOE) in Pediatric Patients With Refractory Solid Tumors.
- Subsequent Malignant Neoplasms in Pediatric Patients Initially Diagnosed With Neuroblastoma.
- Margin status and tumor recurrence after nephron-sparing surgery for bilateral Wilms tumor.
- Intensity modulated radiation therapy provides exCellent local control in high-risk abdominal neuroblastoma.
- Establishment and Characterization of the First Pediatric Adrenocortical Carcinoma XenoGraft Model Identifies Topotecan as a Potential Chemotherapeutic Agent.
- Rapamycin increases neuroblastoma xenoGraft and host stromal derived osteoprotegerin inhibiting osteolytic bone disease in a bone metastasis model.
- Phase I and clinical pharmacology study of bevacizumab, sorafenib, and low-dose cyclophosphamide in children and young adults with refractory/recurrent solid Tumors.
- Jaw Dysfunction Related to Pterygoid and Masseter Muscle Dosimetry after Radiation Therapy in Children and Young Adults with Head-and-Neck Sarcomas.
- A novel EWSR1-CREB3L1 fusion transcript in a case of small Cell osteosarcoma.
- Isolated subcutaneous metastasis of Osteosarcoma 5 years after initial diagnosis.
- A single-arm pilot phase II study of gefitinib and irinotecan in children with newly diagnosed high-risk neuroblastoma.
- Dose escalation of intravenous irinotecan using oral cefpodoxime: A phase I study in pediatric patients with refractory solid Tumors.
- Inherited germline TP53 mutation encodes a protein with an aberrant C-terminal motif in a case of pediatric adrenocortical tumor.
- Epidermal growth factor receptor polymorphisms and risk for toxicity in paediatric patients treated with gefitinib.
- ZygoMycosis originating from an odontogenic infection in a pediatric oncology patient.
- Radiation therapy as part of local control of metastatic neuroblastoma: the St Jude Children's Research Hospital experience.
- Locoregional tumor progression after radiation therapy influences overall survival in pediatric patients with neuroblastoma.
- Tyrosine kinase inhibitor enhances the bioavailability of oral irinotecan in pediatric patients with refractory solid Tumors.
- Phase 1 study of oxaliplatin and irinotecan in pediatric patients with refractory solid Tumors: a children's oncology group study.
- Phase 1 study of an oxaliplatin and etoposide regimen in pediatric patients with recurrent solid Tumors.
- Disease control intervals in high-risk neuroblastoma.
- Avoiding misdiagnosing neuroblastoma as Wilms tumor.
- Significance of pleural effusion in neuroblastoma.
- UGT1A1 promoter genotype correlates with SN-38 pharmacokinetics, but not severe toxicity in patients receiving low-dose irinotecan.
- Pediatric Cancers in the new millennium: dramatic progress, new challenges.
- The impact of early resection of primary neuroblastoma on the survival of children older than 1 year of age with stage 4 Disease: the St. Jude Children's Research Hosp...
- Follicle-derived thyroid Cancer in young people: the Duke experience.
- Expression and function of Trk-C in favourable human neuroblastomas.
Schools
Johns Hopkins University School of Medicine
Duke University
St Jude Chldns Rsch Hospital
Procedures Preformed
- HPC Transplantation (Stem Cell Transplant)
Conditions Treated
- Acute Leukemia
- Adrenal Gland Cancer
- Anemia
- Brain and Nervous System Cancer (incl. Gliomas, Astrocytoma, Schwannoma, Medulloblastoma, Chordoma)
- View All
Doctors Specialties
- Pediatric Hematology
- Oncology
Accepted Insurances
- Aetna HMO
- Choice Plus POS II
- Amerihealth
- Assurant Health
- Blue Card PPO
- Bluegrass Family Health
- Capital Blue Cross
- Cigna HMO
- Cigna PPO
- Open Access Plus
- Commercial Insurance Company
- Coventry Health Care
- Emblem Health
- First Health (Coventry Health Care) PPO
- GEHA
- Community Blue PPO
- Humana
- Medicaid
- Medicare MCR
- PHCS Network PPO
- Qualchoice PPO
- Tricare
- Choice Plus POS
- Navigate HMO
- Navigate POS
- Options PPO
- United Healthcare
- UPMC Health Plan
Awards
- Fellow (FAAP)
Education
-
Duke University Hospital -
Johns Hopkins University School of Medicine
Hospital
-
Penn State Milton S. Hershey Medical Center
Helpful Reviews
Similar Doctors
|
|
Mansi Sachdev, MB
 This Doctor is OpenDoctor Recommended.
|
|
|
Chandrika S. Gowda, MB
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Melanie A. Comito, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. David R. Ungar, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. John E. Neely, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Sonali Lakshminarayanan, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Sunil Muthusami, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Shazia Riaz, MD |